Claud Grigg, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the design and results of the CABOSUN trial in metastatic renal cell carcinoma.
Claud Grigg, MD
Advertisement
Articles by Claud Grigg, MD
Claud Grigg, MD, medical oncologist, Levine Cancer Institute, discusses the future treatment landscape of renal cell carcinoma (RCC).
Claud Grigg, MD, medical oncologist, Levine Cancer Institute, discusses frontline tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC).
Advertisement
Latest Updated Articles
Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCCOctober 22nd 2018
Dr. Grigg on the Future Treatment Landscape of Renal Cell CarcinomaOctober 29th 2018
Dr. Grigg Discusses CABOSUN Trial in mRCCFebruary 11th 2019
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
4
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
5